House of Lords Business
Show full summary

Lord Mendelsohn to ask His Majesty's Government further to the Written Answers by Lord Markham on 11 April (HL6530) and 12 April (HL6941), in which he stated that the DHSC will continue to fund and provide COVID-19 testing and that the welfare of immunocompromised patients remains a priority for the spring booster vaccinations, by what means (1) people eligible for priority treatment when testing positive will be identified and prioritised with the removal of the Webview and Shielding Persons List, and (2) those eligible for future vaccinations because of their vulnerable status will be identified.  HL8302

Question HL8302: tabled on 7 June 2023 and due for answer by 21 June 2023

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Mendelsohn to ask His Majesty's Government further to the Written Answers by Lord Markham on 11 April (HL6530) and 12 April (HL6941), in which he stated that the DHSC will continue to fund and provide COVID-19 testing and that the welfare of immunocompromised patients remains a priority for the spring booster vaccinations, by what means (1) people eligible for priority treatment when testing positive will be identified and prioritised with the removal of the Webview and Shielding Persons List, and (2) those eligible for future vaccinations because of their vulnerable status will be identified.  HL8302
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Mendelsohn
Labour
Life peer